Proposed mechanisms of GLP-1RA-induced acute pancreatitis include pancreatic duct gland hyperplasia, pancreatic ductal obstruction leading to proinflammatory reactions, acinar cell hypertrophy, and pancreatic vascular injury.36 Additionally, another mechanism seen with the use of these drugs could be the increased risk of gallbladder or biliary diseases, especially when used in higher doses, for longer periods of time, and for weight loss.37 Previous animal studies suggested a risk of acute pancreatitis after GLP-1RA-based treatment.38 In addition, an initial analysis of the Food and Drug Administration's (FDA) adverse event reporting databases suggested an increased risk for acute pancreatitis with GLP-1RA-based therapy.39 It is important to note that this type of data analysis may not be the ideal method for comparing adverse event rates between medications

Regardless of which GLP-1 medication your employees are taking, there is also an avenue for them to save money by applying for the Manufacturer's Patient Assistance Program (PAP)
Exendin-4 (Exenatide) mimicks GLP-1 but is much more potent in vivo following parenteral administration (28)
Semaglutide should not be viewed as a cosmetic shortcut
If youre struggling with sleep issues and think GLP-1 therapy might help, dont wait to seek professional guidance